The Important Role of Phosphatidylserine, ADAM17, TNF-Alpha, and Soluble MER on Efferocytosis Activity in Central Obesity
Table 1
Clinical characteristics of the participants.
Variables
Group
value
Control (n = 29)
Obese (n = 56)
Age (years old)
38.5 ± 0.9
39.3 ± 0.7
0.197
BMI (kg/m2)
22.7 ± 0.4
34.1 ± 0.6
<0.001
WC (cm)
84.1 ± 0.9
115.9 ± 1.4
<0.001
SGOT (U/L)
22.2 ± 1.3
30.2 ± 2.2
0.006
SGPT (U/L)
28.7 ± 5.1
52.1 ± 4.2
<0.001
HbA1c (%)
5.3 ± 0.6
6.2 ± 0.2
<0.001
hs-CRP (mg/L)
1.6 ± 0.4
5.2 ± 0.4
<0.001
Total cholesterol (mg/dL)
200.4 ± 6.3
215.9 ± 4.8
0.050
LDL cholesterol (mg/dL)
121.1 ± 5.7
153.5 ± 4.5
<0.001
HDL cholesterol (mg/dL)
51.5 ± 1.8
41.0 ± 0.9
<0.001
Triglycerides (mg/dL)
105.3 ± 8.1
163.3 ± 9.0
<0.001
Non-HDL cholesterol (mg/dL)
148.9 ± 6.0
174.9 ± 4.8
0.001
BP systolic (mmHg)
124.2 ± 2.2
140.6 ± 2.2
<0.001
BP diastolic (mmHg)
79.9 ± 1.6
94.5 ± 1.5
<0.001
All results are expressed as mean ± SEM. BMI, body mass index; WC, waist circumference; SGOT, serum glutamic-oxaloacetic transaminase; SGPT, serum glutamic pyruvic transaminase; HbA1c, hemoglobin A1c; hs-CRP, high-sensitivity C-reactive protein; LDL, low-density lipoprotein; HDL, high-density lipoprotein; BP, blood pressure. Significant in 95% confidence interval using the Mann–Whitney test.
